Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an announcement.
Shanghai Pharmaceuticals Holding Co., Ltd. announced the composition of its board of directors and their respective roles, effective March 13, 2025. This announcement highlights the company’s strategic focus on governance and leadership, potentially impacting its operational efficiency and stakeholder confidence.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. It focuses on the development, manufacturing, and distribution of pharmaceutical products, catering to both domestic and international markets.
YTD Price Performance: -5.83%
Average Trading Volume: 30,224
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $7.82B
For a thorough assessment of 2607 stock, go to TipRanks’ Stock Analysis page.